Pharmacy Times previews enlicitide, survodutide, diet and heart failure risk, and pharmacist-led HF care ahead of the AHA Scientific Sessions in Chicago.
News|Articles|September 22, 2026
- September 2026
- Volume 92
- Issue 9
Multilevel Anticoagulant Stewardship Enhances Patient Safety
Fact checked by: Afton Woodward
A stewardship program combining EHR alerts and pharmacist-led education offers a replicable model for reducing bleeding risk.
Advertisement
Advertisement
Each year, anticoagulants such as apixaban (Eliquis; Bristol Myers Squibb, Pfizer) and rivaroxaban (Xarelto; Johnson & Johnson) account for 5 of every 1000 emergency department visits attributed to medication adverse effects in adults 65 years and older. Among adults aged 45 to 64 years, they account for 1 of every 1000 visits—a rate comparable to that associated with prescription opioids.1
Related to this article
Young adults who vaped daily but never smoked had lower flow-mediated dilation and peak oxygen uptake than peers who used neither product.
Pharmacists can work alongside dermatologists, nurses, other health care professionals to help answer skincare-related questions and help patients understand trial outcomes.
Early metformin may curb insulin starts in gestational diabetes, while a separate analysis ties a history of the condition to advanced CKM syndrome.
Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
RSV hospitalization raised short-term invasive pneumococcal disease risk, especially among unvaccinated individuals.
ADA guidance ties monitoring choices to therapy, risk, and preference. Brooke Hudspeth, PharmD, explains how pharmacists help individualize the plan.
The provider-administered IL-23 inhibitor improved ACR20 response vs placebo after 2 doses in the phase 3 INSPIRE-1 and INSPIRE-2 trials.
Advertisement
Advertisement